is noom glp 1 fda approved Med Microdosing GLP-1 for Weight Loss
Description
and increased insulin early AUC and C-peptide total and early AUCs

Glucagon-like peptide-1 receptor agonist (GLP-1RAs) and more recently Twin-Cretins (GLP+GIP) are frequently used for patients with diabetes and associated obesity

The American Society of Anesthesiologists (ASA) recommends withholding these drugs before surgery, but definitive guidelines remain unclear

Increasing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) raises concern for interactions with warfarin

The FDA also raised concerns about contamination, incorrect dosages, unapproved or harmful ingredients, and counterfeit components in compounded GLP-1s

This guide covers current clinical evidence, milk transfer concerns, and how to evaluate alternatives with your care team